Detalhe da pesquisa
1.
Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre.
Afr Health Sci
; 23(1): 157-169, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545946